688105 Nanjing Vazyme Biotech
- 23.38
- +0.56+2.45%
Nanjing Vazyme Biotech News
Novi Zang\'s progress announcement on the repurchase of the company\'s shares through centralized bidding transactions
Novi Zan: Announcement on the listing and circulation of some restricted shares in the initial public offering of Novi Zan
Novi Zan\'s initial public offering of some restricted shares
Novi Zan\'s announcement on implementing the 2024 interim dividend
Novi Zan\'s announcement on abolishing part of the 2023 Restricted Stock Incentive Plan to grant restricted shares that have not yet been vested
Legal opinion of Beijing Tianyuan Law Firm on matters relating to price adjustments in the 2023 restricted stock incentive plan granted to Nanjing Novizan Biotechnology Co., Ltd., the achievement of ownership conditions for the first time, and the abolition of some restricted shares
The Supervisory Board\'s review opinion on the company\'s 2023 Restricted Stock Incentive Plan granted part of the first vesting period ownership list for the first time
Novi Zane\'s announcement on the 2023 Restricted Stock Incentive Plan for the first time granting part of the first vesting period to meet the eligibility requirements
Novi Zan\'s announcement on adjusting the price granted under the 2023 Restricted Stock Incentive Plan
Novi Zang\'s progress announcement on the repurchase of the company\'s shares through centralized bidding transactions
Novi Zan\'s announcement on adjusting the maximum share repurchase price after implementing the 2023 equity distribution
Novi Zang\'s progress announcement on the repurchase of the company\'s shares through centralized bidding transactions
Announcement on the Progress of Novozymes's Share Repurchase by Centralized Bidding Trading Method.
Announcement on the Progress of Novozymes's Share Repurchase by Centralized Bidding Trading Method.
Notice of Implementation of Annual Equity Distribution of Nuoweizan in 2023.
Announcement by Nouveau International on the adjustment of the total amount of cash dividends for profit distribution for 2023.
Announcement on the Progress of Novozymes's Share Repurchase by Centralized Bidding Trading Method.
Novi Zan's announcement on the repurchase ratio of the company's shares through centralized bidding transactions reaching 1% of the total share capital and the progress of the repurchase
Novi Zan's announcement on changing the use of shares to be repurchased
Novi Zan's announcement on the 2024 mid-term dividend plan
Analysis
Price Target
No Data
No Data